董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Dwight Egan | 男 | Chief Executive Officer, President and Chairman of the Board | 72 | 52.88万美元 | 3.43 | 2026-11-13 |
| Richard Serbin | 男 | Independent Director | 81 | 13.78万美元 | 1.27 | 2026-11-13 |
| Eugene Durenard | 男 | Independent Director | 56 | 14.08万美元 | 1.20 | 2026-11-13 |
| Edward Murphy | 男 | Independent Director | 61 | 13.78万美元 | 1.41 | 2026-11-13 |
| James Nelson | 男 | Independent Director | 73 | 13.78万美元 | 1.36 | 2026-11-13 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Dwight Egan | 男 | Chief Executive Officer, President and Chairman of the Board | 72 | 52.88万美元 | 3.43 | 2026-11-13 |
| Richard Abbott | 男 | President | 54 | 36.00万美元 | 2.50 | 2026-11-13 |
| Daniel Bohrer | 男 | Executive Vice President of Finance and Accounting and Principal Financial Officer | 49 | 未披露 | 未持股 | 2026-11-13 |
董事简历
中英对照 | 中文 | 英文- Dwight Egan
-
德怀特·伊根担任首席执行官，自2013年4月起担任公司高级管理人员和董事。Egan先生从1999年2月至今，一直从事私人投资业务。他曾是Data Broadcasting Corporation的高级主管，该公司是一家领先的无线、实时金融市场数据、新闻和复杂的固定收益投资组合分析提供商，从1995年到1999年，为27,000名个人和专业投资者提供服务。他于1984年至1995年共同创立并担任Broadcast International，Inc.的首席执行官和董事会主席，当时Data Broadcasting Corporation收购了Broadcast International并创建了CBS MarketWatch，这是一家领先的财经新闻网站，并参与了其首次公开募股。
Dwight Egan serves as Chief Executive Officer and has been an officer and director of the Company since April 2013. Mr. Egan has been engaged in private investment business from February 1999 to the present. He was a senior executive at Data Broadcasting Corporation, a leading provider of wireless, real-time financial market data, news and sophisticated fixed- income portfolio analytics to 27,000 individual and professional investors from 1995 to 1999. He co-founded and served as CEO and Chairman of the Board of Broadcast International, Inc. from 1984 to 1995, when Data Broadcasting Corporation acquired Broadcast International and created CBS MarketWatch, a leading financial news site and participated in its initial public offering. - 德怀特·伊根担任首席执行官，自2013年4月起担任公司高级管理人员和董事。Egan先生从1999年2月至今，一直从事私人投资业务。他曾是Data Broadcasting Corporation的高级主管，该公司是一家领先的无线、实时金融市场数据、新闻和复杂的固定收益投资组合分析提供商，从1995年到1999年，为27,000名个人和专业投资者提供服务。他于1984年至1995年共同创立并担任Broadcast International，Inc.的首席执行官和董事会主席，当时Data Broadcasting Corporation收购了Broadcast International并创建了CBS MarketWatch，这是一家领先的财经新闻网站，并参与了其首次公开募股。
- Dwight Egan serves as Chief Executive Officer and has been an officer and director of the Company since April 2013. Mr. Egan has been engaged in private investment business from February 1999 to the present. He was a senior executive at Data Broadcasting Corporation, a leading provider of wireless, real-time financial market data, news and sophisticated fixed- income portfolio analytics to 27,000 individual and professional investors from 1995 to 1999. He co-founded and served as CEO and Chairman of the Board of Broadcast International, Inc. from 1984 to 1995, when Data Broadcasting Corporation acquired Broadcast International and created CBS MarketWatch, a leading financial news site and participated in its initial public offering.
- Richard Serbin
-
Richard Serbin自2017年5月起担任董事会成员。Serbin先生目前担任医疗保健行业多家公司的顾问。2024年1月至今，任平台药业董事局主席。他于2013年6月1日至2014年7月15日担任Life Science Institute，LLC的企业发展总裁和内部法律顾问。2013年5月至2014年6月担任Viropro Inc.董事。他曾于2006年10月至2007年9月担任Mazal Plant Pharmaceuticals Inc.的业务顾问委员会负责人，并担任其业务顾问委员会成员。2002年7月至2005年9月15日任Optigenex Inc.首席执行官，2004年7月至2005年9月任董事。从1999年1月至2002年7月，Serbin先生担任多家制药公司的顾问。他曾担任布拉德利制药公司的总裁。他曾在强生旗下Ortho Pharmaceuticals担任企业发展副总裁，并在露华浓强生和先灵葆雅从事专利和FDA法律业务。他曾担任先灵葆雅公司的专利律师，以及露华浓公司和强生公司的首席FDA法律顾问。随后，他曾任职于露华浓公司，担任其首席食品、药品和化妆品顾问。他创立了Radius Scientific Corporation。他曾是强生的企业发展副总裁，后来基于斯坦福医学院开发的技术，领导了一家成功的公募企业。塞尔宾先生职业生涯的很大一部分时间都专注于国际市场和客户。在强生任职期间，Serbin先生曾在16家美国和国际子公司的董事会任职，包括Ethicon、Ortho、J & J Consumer Products、Pittman Moore、MC Neil和J & J Development Corporation。他参与了多项国际收购和战略关系，并担任其多家国际子公司的董事会成员，包括印度、香港、日本、台湾、德国和英国的子公司。Serbin先生拥有罗格斯大学和罗格斯大学药学院的药学学士和药学学士学位，Seton Hall法学院的法学博士学位和纽约大学法学院的贸易法规和法律硕士学位。
Richard Serbin has been a member of board of directors since May 2017. Mr. Serbin currently serves as a consultant to many companies in the healthcare industry. Since January 2024, he has served as Chairman of the Board of Directors of Platform Pharmaceuticals. He was the President of Corporate Development and In House Legal Counsel at Life Science Institute, LLC, from June 1, 2013 to July 15, 2014. He served as Director at Viropro Inc. from May 2013 to June 2014. He was Head of Business Advisory Board at Mazal Plant Pharmaceuticals Inc. from October 2006 to September 2007 and also served as its Member of Business Advisory Board. He served as Chief Executive Officer of Optigenex Inc. from July 2002 to September 15, 2005 and a director from July 2004 to September 2005. From January 1999 until July 2002 Mr. Serbin served as a consultant to various pharmaceutical companies. He served as the President of Bradley Pharmaceuticals. He served as Vice President of Corporate Development at Ortho Pharmaceuticals, a Johnson & Johnson subsidiary, and practiced Patent and FDA law at Revlon Johnson & Johnson and Schering Plough. He served as Patent Attorney for Schering Plough Corporation and Chief FDA Counsel for Revlon Corporation and Johnson and Johnson Corporation. Subsequently, he worked at Revlon Corporation, as its Chief Food, Drug and Cosmetic Counsel. He founded Radius Scientific Corporation. He was J&J's Vice President of Corporate Development, and later led a successful public offering venture based on technology developed at Stanford Medical School. Mr. Serbin spent a large portion of his career focusing on international markets and clients. While at J&J, Mr. Serbin served on the board of directors of 16 US and international subsidiary companies, including Ethicon, Ortho, J&J Consumer Products, Pittman Moore, Mc Neil, and J&J Development Corporation. He worked on multiple international acquisitions and strategic relationships, and sat on the board of directors of several of its international subsidiaries, including those in India, Hong Kong, Japan, Taiwan, Germany, and England. Mr. Serbin has a B.S. and a B. Pharmacy from Rutgers University and Rutgers University College of Pharmacy, a J.D. degree from Seton Hall Law School and a Master's Degree in Trade Regulations and Law from NYU Law School. - Richard Serbin自2017年5月起担任董事会成员。Serbin先生目前担任医疗保健行业多家公司的顾问。2024年1月至今，任平台药业董事局主席。他于2013年6月1日至2014年7月15日担任Life Science Institute，LLC的企业发展总裁和内部法律顾问。2013年5月至2014年6月担任Viropro Inc.董事。他曾于2006年10月至2007年9月担任Mazal Plant Pharmaceuticals Inc.的业务顾问委员会负责人，并担任其业务顾问委员会成员。2002年7月至2005年9月15日任Optigenex Inc.首席执行官，2004年7月至2005年9月任董事。从1999年1月至2002年7月，Serbin先生担任多家制药公司的顾问。他曾担任布拉德利制药公司的总裁。他曾在强生旗下Ortho Pharmaceuticals担任企业发展副总裁，并在露华浓强生和先灵葆雅从事专利和FDA法律业务。他曾担任先灵葆雅公司的专利律师，以及露华浓公司和强生公司的首席FDA法律顾问。随后，他曾任职于露华浓公司，担任其首席食品、药品和化妆品顾问。他创立了Radius Scientific Corporation。他曾是强生的企业发展副总裁，后来基于斯坦福医学院开发的技术，领导了一家成功的公募企业。塞尔宾先生职业生涯的很大一部分时间都专注于国际市场和客户。在强生任职期间，Serbin先生曾在16家美国和国际子公司的董事会任职，包括Ethicon、Ortho、J & J Consumer Products、Pittman Moore、MC Neil和J & J Development Corporation。他参与了多项国际收购和战略关系，并担任其多家国际子公司的董事会成员，包括印度、香港、日本、台湾、德国和英国的子公司。Serbin先生拥有罗格斯大学和罗格斯大学药学院的药学学士和药学学士学位，Seton Hall法学院的法学博士学位和纽约大学法学院的贸易法规和法律硕士学位。
- Richard Serbin has been a member of board of directors since May 2017. Mr. Serbin currently serves as a consultant to many companies in the healthcare industry. Since January 2024, he has served as Chairman of the Board of Directors of Platform Pharmaceuticals. He was the President of Corporate Development and In House Legal Counsel at Life Science Institute, LLC, from June 1, 2013 to July 15, 2014. He served as Director at Viropro Inc. from May 2013 to June 2014. He was Head of Business Advisory Board at Mazal Plant Pharmaceuticals Inc. from October 2006 to September 2007 and also served as its Member of Business Advisory Board. He served as Chief Executive Officer of Optigenex Inc. from July 2002 to September 15, 2005 and a director from July 2004 to September 2005. From January 1999 until July 2002 Mr. Serbin served as a consultant to various pharmaceutical companies. He served as the President of Bradley Pharmaceuticals. He served as Vice President of Corporate Development at Ortho Pharmaceuticals, a Johnson & Johnson subsidiary, and practiced Patent and FDA law at Revlon Johnson & Johnson and Schering Plough. He served as Patent Attorney for Schering Plough Corporation and Chief FDA Counsel for Revlon Corporation and Johnson and Johnson Corporation. Subsequently, he worked at Revlon Corporation, as its Chief Food, Drug and Cosmetic Counsel. He founded Radius Scientific Corporation. He was J&J's Vice President of Corporate Development, and later led a successful public offering venture based on technology developed at Stanford Medical School. Mr. Serbin spent a large portion of his career focusing on international markets and clients. While at J&J, Mr. Serbin served on the board of directors of 16 US and international subsidiary companies, including Ethicon, Ortho, J&J Consumer Products, Pittman Moore, Mc Neil, and J&J Development Corporation. He worked on multiple international acquisitions and strategic relationships, and sat on the board of directors of several of its international subsidiaries, including those in India, Hong Kong, Japan, Taiwan, Germany, and England. Mr. Serbin has a B.S. and a B. Pharmacy from Rutgers University and Rutgers University College of Pharmacy, a J.D. degree from Seton Hall Law School and a Master's Degree in Trade Regulations and Law from NYU Law School.
- Eugene Durenard
-
Eugene Durenard自2019年6月起担任董事会成员。杜伦纳德博士是双曲线控股公司的创始人和首席执行官，双曲线控股公司是一家总部位于瑞士的控股、管理咨询和战略咨询公司，专门从事医疗保健。几年来，他一直在与家族办公室合作开展直接投资和专注于生命科学的慈善事业。他在生物技术和医疗技术领域的几家私营公司的咨询和执行董事会任职，其中一些是他共同创立的。在所罗门兄弟公司和伦敦的瑞士信贷从事自营研究和交易的初步职业生涯后，他在百慕大共同创立了Orion Investment Management，专门为机构和私人客户提供量化资产和负债管理。随后，他将其卖给了Capital G Bank，并共同领导了他们的资产管理。杜伦纳德博士花了几年时间，与生命科学创新的各种国际集群、经营医疗保健业务的家庭和全球行业领导者建立了个人联系。他定期访问实验室和孵化器，与领先的科学家和创新者会面，以便跟上当前的趋势和发展。他的建议基于一项结合了科学深度知识、竞争力量和金融专业知识的透彻分析。曾在资产负债管理、公共卫生以及《专业自动化交易——理论与实践》（Wiley2013）一书中发表多篇文章。
Eugene Durenard has been a member of board of directors since June 2019. Dr. Durenard is the Founder and CEO of Hyperbolic Holdings, a Swiss based holding, management consulting and strategy advisory company specialized in healthcare. For several years he has been working with family offices on direct investments and philanthropy focused on life sciences. He serves on advisory and executive boards of a few private companies in the Biotech and MedTech sectors, some of which he co founded. After an initial career in proprietary research and trading at Salomon Brothers and Credit Suisse in London, he co founded Orion Investment Management in Bermuda specializing in quantitative asset and liability management for institutions and private clients. He subsequently sold it to Capital G Bank and co headed their asset management. Dr. Durenard spent several years establishing personal connections with various international clusters of life science innovation, families operating healthcare businesses and industry leaders globally. He regularly visits labs and incubators, meets with leading scientists and innovators in order to keep abreast of current trends and developments. His advice is based on a thorough analysis that combines in depth knowledge of science, competitive forces and financial expertise. He has published several articles in asset liability management, in public health as well as the book "Professional Automated Trading — Theory and Practice" (Wiley 2013). - Eugene Durenard自2019年6月起担任董事会成员。杜伦纳德博士是双曲线控股公司的创始人和首席执行官，双曲线控股公司是一家总部位于瑞士的控股、管理咨询和战略咨询公司，专门从事医疗保健。几年来，他一直在与家族办公室合作开展直接投资和专注于生命科学的慈善事业。他在生物技术和医疗技术领域的几家私营公司的咨询和执行董事会任职，其中一些是他共同创立的。在所罗门兄弟公司和伦敦的瑞士信贷从事自营研究和交易的初步职业生涯后，他在百慕大共同创立了Orion Investment Management，专门为机构和私人客户提供量化资产和负债管理。随后，他将其卖给了Capital G Bank，并共同领导了他们的资产管理。杜伦纳德博士花了几年时间，与生命科学创新的各种国际集群、经营医疗保健业务的家庭和全球行业领导者建立了个人联系。他定期访问实验室和孵化器，与领先的科学家和创新者会面，以便跟上当前的趋势和发展。他的建议基于一项结合了科学深度知识、竞争力量和金融专业知识的透彻分析。曾在资产负债管理、公共卫生以及《专业自动化交易——理论与实践》（Wiley2013）一书中发表多篇文章。
- Eugene Durenard has been a member of board of directors since June 2019. Dr. Durenard is the Founder and CEO of Hyperbolic Holdings, a Swiss based holding, management consulting and strategy advisory company specialized in healthcare. For several years he has been working with family offices on direct investments and philanthropy focused on life sciences. He serves on advisory and executive boards of a few private companies in the Biotech and MedTech sectors, some of which he co founded. After an initial career in proprietary research and trading at Salomon Brothers and Credit Suisse in London, he co founded Orion Investment Management in Bermuda specializing in quantitative asset and liability management for institutions and private clients. He subsequently sold it to Capital G Bank and co headed their asset management. Dr. Durenard spent several years establishing personal connections with various international clusters of life science innovation, families operating healthcare businesses and industry leaders globally. He regularly visits labs and incubators, meets with leading scientists and innovators in order to keep abreast of current trends and developments. His advice is based on a thorough analysis that combines in depth knowledge of science, competitive forces and financial expertise. He has published several articles in asset liability management, in public health as well as the book "Professional Automated Trading — Theory and Practice" (Wiley 2013).
- Edward Murphy
-
Edward Murphy自2019年6月起担任董事会成员。自1999年12月起，Murphy先生担任高级副总裁兼私人投资公司都福投资有限公司的合伙人。在其整个职业生涯中，墨菲先生的职责包括对房地产和金融服务领域的各类投资项目进行投资分析。目前，墨菲先生担任多家加拿大和美国公开报道公司的董事会成员，这些公司在各个行业都有兴趣。他自2016年1月起担任Empire Minerals Corporation Inc.的董事，自1997年4月30日起担任Mosport Park Entertainment Corporation的董事，直至2011年6月成为Digicrypts Blockchain Solutions Inc.直至2022年11月辞职，自2018年2月起担任Lakefield Marketing Corporation的董事，自2019年9月起担任Credo Resources Inc.的首席执行官/首席财务官兼董事，自2021年7月起担任Essex Oil Ltd.的董事，自2021年11月起担任Darkhorse Technologies Ltd.的董事。2003年5月至2017年12月任Aurquest Resources董事。他还自2023年4月起担任E Ventures Inc.的董事。
Edward Murphy has been a member of board of directors since June 2019. Since December 1999, Mr. Murphy has served as a senior vice president and a partner of Dover Investments Ltd., a private investment firm. Throughout his career, Mr. Murphy's duties have included investment analysis of various types of investment projects in real estate and financial services. Currently, Mr. Murphy serves on the board of directors of several Canadian and American publicly reporting companies that have interests in various industries. He has been a Director at Empire Minerals Corporation Inc. since January 2016, at the Mosport Park Entertainment Corporation from April 30, 1997 until it became Digicrypts Blockchain Solutions Inc. in June 2011 until he resigned in November 2022, at Lakefield Marketing Corporation since February 2018, CEO/CFO and Director of Credo Resources Inc. since September 2019, and at Essex Oil Ltd. since July 2021, and at Darkhorse Technologies Ltd. since November 2021. He served as a Director at Aurquest Resources from May 2003 to December 2017. He has also served as Director at E Ventures Inc. since April 2023. - Edward Murphy自2019年6月起担任董事会成员。自1999年12月起，Murphy先生担任高级副总裁兼私人投资公司都福投资有限公司的合伙人。在其整个职业生涯中，墨菲先生的职责包括对房地产和金融服务领域的各类投资项目进行投资分析。目前，墨菲先生担任多家加拿大和美国公开报道公司的董事会成员，这些公司在各个行业都有兴趣。他自2016年1月起担任Empire Minerals Corporation Inc.的董事，自1997年4月30日起担任Mosport Park Entertainment Corporation的董事，直至2011年6月成为Digicrypts Blockchain Solutions Inc.直至2022年11月辞职，自2018年2月起担任Lakefield Marketing Corporation的董事，自2019年9月起担任Credo Resources Inc.的首席执行官/首席财务官兼董事，自2021年7月起担任Essex Oil Ltd.的董事，自2021年11月起担任Darkhorse Technologies Ltd.的董事。2003年5月至2017年12月任Aurquest Resources董事。他还自2023年4月起担任E Ventures Inc.的董事。
- Edward Murphy has been a member of board of directors since June 2019. Since December 1999, Mr. Murphy has served as a senior vice president and a partner of Dover Investments Ltd., a private investment firm. Throughout his career, Mr. Murphy's duties have included investment analysis of various types of investment projects in real estate and financial services. Currently, Mr. Murphy serves on the board of directors of several Canadian and American publicly reporting companies that have interests in various industries. He has been a Director at Empire Minerals Corporation Inc. since January 2016, at the Mosport Park Entertainment Corporation from April 30, 1997 until it became Digicrypts Blockchain Solutions Inc. in June 2011 until he resigned in November 2022, at Lakefield Marketing Corporation since February 2018, CEO/CFO and Director of Credo Resources Inc. since September 2019, and at Essex Oil Ltd. since July 2021, and at Darkhorse Technologies Ltd. since November 2021. He served as a Director at Aurquest Resources from May 2003 to December 2017. He has also served as Director at E Ventures Inc. since April 2023.
- James Nelson
-
James Nelson自2019年6月起担任董事会成员。Nelson先生是Sunworks, Inc.的退休董事长兼首席执行官，这是一家在纳斯达克上市的商业、农业和住宅太阳能集成商，他于2010年10月帮助创立了这家公司。纳尔逊先生职业生涯的大部分时间都在私募股权领域工作，担任Peterson Partners和Millennial Capital Partners的普通合伙人。除了投资和财务职责外，他还担任过其公司旗下两家投资组合公司的首席执行官。在从事私募股权投资多年之前，Nelson先生曾在Banana Republic担任营销副总裁，负责管理公司范围内的营销以及公司的国际扩张计划。他还是Banana Republic目录部门的总经理。他曾在价值数十亿美元的食品服务公司Saga Corporation担任营销和企业发展副总裁。尼尔森35多年前在商业战略咨询公司贝恩公司开始了他的高管生涯，在那里他管理着遍布四大洲的顾问团队。Nelson先生获得了杨百翰大学的MBA学位，在那里他以优异成绩毕业，并被评为杰出的工商管理硕士毕业生。
James Nelson has been a member of board of directors since June 2019. Mr. Nelson is the retired Chairman and CEO of Sunworks, Inc., a NASDAQ traded commercial, agriculture, and residential solar Integrator which he helped found in October 2010. Mr. Nelson spent most of his career working in private equity as a general partner with Peterson Partners and with Millennial Capital Partners. In addition to his investment and financial responsibilities, he served as CEO of two of his firms' portfolio companies. Prior to his years in private equity, Mr. Nelson served as Vice President of Marketing at Banana Republic, where he managed company wide marketing, as well as the company's international expansion initiative. He was also general manager for Banana Republic's catalog division. He was Vice President of Marketing and Corporate Development at Saga Corporation, a multi billion dollar food service company. Mr. Nelson began his executive career over 35 years ago at Bain and Company, a business strategy consulting firm, where he managed teams of consultants on four continents. Mr. Nelson received his MBA from Brigham Young University, where he graduated summa cum laude and was named the Outstanding Master of Business Administration Graduate. - James Nelson自2019年6月起担任董事会成员。Nelson先生是Sunworks, Inc.的退休董事长兼首席执行官，这是一家在纳斯达克上市的商业、农业和住宅太阳能集成商，他于2010年10月帮助创立了这家公司。纳尔逊先生职业生涯的大部分时间都在私募股权领域工作，担任Peterson Partners和Millennial Capital Partners的普通合伙人。除了投资和财务职责外，他还担任过其公司旗下两家投资组合公司的首席执行官。在从事私募股权投资多年之前，Nelson先生曾在Banana Republic担任营销副总裁，负责管理公司范围内的营销以及公司的国际扩张计划。他还是Banana Republic目录部门的总经理。他曾在价值数十亿美元的食品服务公司Saga Corporation担任营销和企业发展副总裁。尼尔森35多年前在商业战略咨询公司贝恩公司开始了他的高管生涯，在那里他管理着遍布四大洲的顾问团队。Nelson先生获得了杨百翰大学的MBA学位，在那里他以优异成绩毕业，并被评为杰出的工商管理硕士毕业生。
- James Nelson has been a member of board of directors since June 2019. Mr. Nelson is the retired Chairman and CEO of Sunworks, Inc., a NASDAQ traded commercial, agriculture, and residential solar Integrator which he helped found in October 2010. Mr. Nelson spent most of his career working in private equity as a general partner with Peterson Partners and with Millennial Capital Partners. In addition to his investment and financial responsibilities, he served as CEO of two of his firms' portfolio companies. Prior to his years in private equity, Mr. Nelson served as Vice President of Marketing at Banana Republic, where he managed company wide marketing, as well as the company's international expansion initiative. He was also general manager for Banana Republic's catalog division. He was Vice President of Marketing and Corporate Development at Saga Corporation, a multi billion dollar food service company. Mr. Nelson began his executive career over 35 years ago at Bain and Company, a business strategy consulting firm, where he managed teams of consultants on four continents. Mr. Nelson received his MBA from Brigham Young University, where he graduated summa cum laude and was named the Outstanding Master of Business Administration Graduate.
高管简历
中英对照 | 中文 | 英文- Dwight Egan
德怀特·伊根担任首席执行官，自2013年4月起担任公司高级管理人员和董事。Egan先生从1999年2月至今，一直从事私人投资业务。他曾是Data Broadcasting Corporation的高级主管，该公司是一家领先的无线、实时金融市场数据、新闻和复杂的固定收益投资组合分析提供商，从1995年到1999年，为27,000名个人和专业投资者提供服务。他于1984年至1995年共同创立并担任Broadcast International，Inc.的首席执行官和董事会主席，当时Data Broadcasting Corporation收购了Broadcast International并创建了CBS MarketWatch，这是一家领先的财经新闻网站，并参与了其首次公开募股。
Dwight Egan serves as Chief Executive Officer and has been an officer and director of the Company since April 2013. Mr. Egan has been engaged in private investment business from February 1999 to the present. He was a senior executive at Data Broadcasting Corporation, a leading provider of wireless, real-time financial market data, news and sophisticated fixed- income portfolio analytics to 27,000 individual and professional investors from 1995 to 1999. He co-founded and served as CEO and Chairman of the Board of Broadcast International, Inc. from 1984 to 1995, when Data Broadcasting Corporation acquired Broadcast International and created CBS MarketWatch, a leading financial news site and participated in its initial public offering.- 德怀特·伊根担任首席执行官，自2013年4月起担任公司高级管理人员和董事。Egan先生从1999年2月至今，一直从事私人投资业务。他曾是Data Broadcasting Corporation的高级主管，该公司是一家领先的无线、实时金融市场数据、新闻和复杂的固定收益投资组合分析提供商，从1995年到1999年，为27,000名个人和专业投资者提供服务。他于1984年至1995年共同创立并担任Broadcast International，Inc.的首席执行官和董事会主席，当时Data Broadcasting Corporation收购了Broadcast International并创建了CBS MarketWatch，这是一家领先的财经新闻网站，并参与了其首次公开募股。
- Dwight Egan serves as Chief Executive Officer and has been an officer and director of the Company since April 2013. Mr. Egan has been engaged in private investment business from February 1999 to the present. He was a senior executive at Data Broadcasting Corporation, a leading provider of wireless, real-time financial market data, news and sophisticated fixed- income portfolio analytics to 27,000 individual and professional investors from 1995 to 1999. He co-founded and served as CEO and Chairman of the Board of Broadcast International, Inc. from 1984 to 1995, when Data Broadcasting Corporation acquired Broadcast International and created CBS MarketWatch, a leading financial news site and participated in its initial public offering.
- Richard Abbott
Richard Abbott自2024年3月起担任Co Diagnostics总裁。在被任命为总裁之前，2021年1月至2024年3月，Abbott先生担任Advanced Conceptions，Inc.的总裁，该公司是一家私营医疗设备公司，专注于设计解决具有挑战性的跨学科问题的自动化仪器。Advanced Conceptions是Co Diagnostics，Inc.的全资子公司。从2018年9月到2021年1月，Abbott先生是SaltRidge，LLC的合伙人，通过该公司，他向Advanced Conceptions提供管理服务和其他咨询服务。2017年8月至2018年8月，担任私人控股的Vilicus首席技术官，Vilicus是一家以云为中心的室内农业物联网设备网络提供商。从2016年10月到2017年7月，Abbott先生担任Fenome的首席技术官，这是一家私营公司，专注于通过生长和结果期间的环境控制来操纵室内农业作物的表型表达。Abbott先生拥有沃顿商学院的工商管理硕士学位以及杨百翰大学的科学、机械工程硕士学位和机械工程学士学位。
Richard Abbott has served as President of Co Diagnostics since March 2024. Prior to being appointed as President, from January 2021 to March 2024, Mr. Abbott served as President of Advanced Conceptions, Inc., a privately held medical device company focused on the design of automated instruments that solve challenging cross disciplinary problems. Advanced Conceptions is a wholly owned subsidiary of Co Diagnostics, Inc. From September 2018 to January 2021, Mr. Abbott was a partner in SaltRidge, LLC through which he provided management services to Advanced Conceptions and other consulting services. From August 2017 to August 2018, he served as the Chief Technology Officer for privately held Vilicus, a cloud centered network provider of IoT devices for indoor agriculture. From October 2016 to July 2017, Mr. Abbott served as the Chief Technology Officer for Fenome, a private company focused on the manipulation of phenotypic expression of indoor agriculture crops via environmental control during growth and fruiting. Mr. Abbott holds a Master of Business Administration from The Wharton School and a Master of Science, Mechanical Engineering and a Bachelors Mechanical Engineering from Brigham Young University.- Richard Abbott自2024年3月起担任Co Diagnostics总裁。在被任命为总裁之前，2021年1月至2024年3月，Abbott先生担任Advanced Conceptions，Inc.的总裁，该公司是一家私营医疗设备公司，专注于设计解决具有挑战性的跨学科问题的自动化仪器。Advanced Conceptions是Co Diagnostics，Inc.的全资子公司。从2018年9月到2021年1月，Abbott先生是SaltRidge，LLC的合伙人，通过该公司，他向Advanced Conceptions提供管理服务和其他咨询服务。2017年8月至2018年8月，担任私人控股的Vilicus首席技术官，Vilicus是一家以云为中心的室内农业物联网设备网络提供商。从2016年10月到2017年7月，Abbott先生担任Fenome的首席技术官，这是一家私营公司，专注于通过生长和结果期间的环境控制来操纵室内农业作物的表型表达。Abbott先生拥有沃顿商学院的工商管理硕士学位以及杨百翰大学的科学、机械工程硕士学位和机械工程学士学位。
- Richard Abbott has served as President of Co Diagnostics since March 2024. Prior to being appointed as President, from January 2021 to March 2024, Mr. Abbott served as President of Advanced Conceptions, Inc., a privately held medical device company focused on the design of automated instruments that solve challenging cross disciplinary problems. Advanced Conceptions is a wholly owned subsidiary of Co Diagnostics, Inc. From September 2018 to January 2021, Mr. Abbott was a partner in SaltRidge, LLC through which he provided management services to Advanced Conceptions and other consulting services. From August 2017 to August 2018, he served as the Chief Technology Officer for privately held Vilicus, a cloud centered network provider of IoT devices for indoor agriculture. From October 2016 to July 2017, Mr. Abbott served as the Chief Technology Officer for Fenome, a private company focused on the manipulation of phenotypic expression of indoor agriculture crops via environmental control during growth and fruiting. Mr. Abbott holds a Master of Business Administration from The Wharton School and a Master of Science, Mechanical Engineering and a Bachelors Mechanical Engineering from Brigham Young University.
- Daniel Bohrer
Daniel Bohrer于2026年9月成为财务和会计部执行副总裁。2021年9月至2026年9月，Bohrer先生担任财务和会计部副总裁。从2016年10月到2021年9月，Bohrer先生担任Workfront，Inc.（于2020年被Adobe，Inc.收购）的会计总监。从2014年1月到2016年10月，Bohrer先生在安永会计师事务所担任鉴证高级经理。Bohrer先生拥有犹他州立大学工商管理硕士学位和会计学学士学位，是犹他州的持牌注册会计师。
Daniel Bohrer became Executive Vice President of Finance and Accounting in September 2026. From September 2021 to September 2026, Mr. Bohrer served as Vice President of Finance and Accounting. From October 2016 through September 2021, Mr. Bohrer served as the Director of Accounting for Workfront, Inc. (acquired by Adobe, Inc. in 2020). From January 2014 through October 2016, Mr. Bohrer served as an Assurance Senior Manager at Ernst & Young. Mr. Bohrer holds a Master of Business Administration and Bachelor of Science in Accounting from Utah State University and is a licensed CPA in the State of Utah.- Daniel Bohrer于2026年9月成为财务和会计部执行副总裁。2021年9月至2026年9月，Bohrer先生担任财务和会计部副总裁。从2016年10月到2021年9月，Bohrer先生担任Workfront，Inc.（于2020年被Adobe，Inc.收购）的会计总监。从2014年1月到2016年10月，Bohrer先生在安永会计师事务所担任鉴证高级经理。Bohrer先生拥有犹他州立大学工商管理硕士学位和会计学学士学位，是犹他州的持牌注册会计师。
- Daniel Bohrer became Executive Vice President of Finance and Accounting in September 2026. From September 2021 to September 2026, Mr. Bohrer served as Vice President of Finance and Accounting. From October 2016 through September 2021, Mr. Bohrer served as the Director of Accounting for Workfront, Inc. (acquired by Adobe, Inc. in 2020). From January 2014 through October 2016, Mr. Bohrer served as an Assurance Senior Manager at Ernst & Young. Mr. Bohrer holds a Master of Business Administration and Bachelor of Science in Accounting from Utah State University and is a licensed CPA in the State of Utah.